Reduced susceptibility to cefepime among Escherichia coli clinical isolates producing novel variants of CMY-2 β-lactamase

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 7, 2009, Pages 3159-3161

  Doi, Yohei ^a   Paterson, David L ^a,b   Adams Haduch, Jennifer M ^a   Sidjabat, Hanna E ^a   O'Keefe, Alexandra ^a   Endimiani, Andrea ^c,d   Bonomo, Robert A ^c,d  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BETA LACTAMASE; BETA LACTAMASE CMY 2; CEFEPIME; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BLA CMY GENE; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CEPHALOSPORINS; ESCHERICHIA COLI; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 67649994326     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00133-09     Document Type: Article

References (13)

1. Barnaud, G., Y. Benzerara, J. Gravisse, L. Raskine, M. J. Sanson-Le Pors, R. Labia, and G. Arlet. 2004. Selection during cefepime treatment of a new cephalosporinase variant with extended-spectrum resistance to cefepime in an Enterobacter aerogenes clinical isolate. Antimicrob. Agents Chemother. 48:1040-1042.
2. Barnaud, G., R. Labia, L. Raskine, M. J. Sanson-Le Pors, A. Philippon, and G. Arlet. 2001. Extension of resistance to cefepime and cefpirome associated to a six-amino-acid deletion in the H-10 helix of the cephalosporinase of an Enterobacter cloacae clinical isolate. FEMS Microbiol. Lett. 195:185-190.
3. D'Andrea, M. M., E. Nucleo, F. Luzzaro, T. Giani, R. Migliavacca, F. Vailati, V. Kroumova, L. Pagani, and G. M. Rossolini. 2006. CMY-16, a novel acquired AmpC-type β-lactamase of the CMY/LAT lineage in multifocal monophyletic isolates of Proteus mirabilis from northern Italy. Antimicrob. Agents Chemother. 50:618-624.
4. de Oliveira Garcia, D., Y. Doi, D. Szabo, J. M. Adams-Haduch, T. M. I. Vaz, D. Leite, M. C. Padoveze, M. P. Freire, F. P. Silveira, and D. L. Paterson. 2008. Multiclonal outbreak of Klebsiella pneumoniae producing extended-spectrum β-lactamase CTX-M-2 and novel variant CTX-M-59 in a neonatal intensive care unit in Brazil. Antimicrob. Agents Chemother. 52:1790-1793.
5. Doi, Y., J. Wachino, M. Ishiguro, H. Kurokawa, K. Yamane, N. Shibata, K. Shibayama, K. Yokoyama, H. Kato, T. Yagi, and Y. Arakawa. 2004. Inhibitor-sensitive AmpC β-lactamase variant produced by an Escherichia coli clinical isolate resistant to oxyiminocephalosporins and cephamycins. Antimicrob. Agents Chemother. 48:2652-2658.
6. Galleni, M., F. Lindberg, S. Normark, S. Cole, N. Honore, B. Joris, and J. M. Frere. 1988. Sequence and comparative analysis of three Enterobacter cloacae ampC beta-lactamase genes and their products. Biochem. J. 250:753-760.
7. Kim, J. Y., H. I. Jung, Y. J. An, J. H. Lee, S. J. Kim, S. H. Jeong, K. J. Lee, P. G. Suh, H. S. Lee, S. H. Lee, and S. S. Cha. 2006. Structural basis for the extended substrate spectrum of CMY-10, a plasmid-encoded class C β-lactamase. Mol. Microbiol. 60:907-916.
8. Mammeri, H., L. Poirel, P. Bemer, H. Drugeon, and P. Nordmann. 2004. Resistance to cefepime and cefpirome due to a 4-amino-acid deletion in the chromosome-encoded AmpC β-lactamase of a Serratia marcescens clinical isolate. Antimicrob. Agents Chemother. 48:716-720.
9. Mammeri, H., L. Poirel, and P. Nordmann. 2007. Extension of the hydrolysis spectrum of AmpC β-lactamase of Escherichia coli due to amino acid insertion in the H-10 helix. J. Antimicrob. Chemother. 60:490-494.
10. Philippon, A., G. Arlet, and G. A. Jacoby. 2002. Plasmid-determined AmpC-type β-lactamases. Antimicrob. Agents Chemother. 46:1-11.
11. Tenover, F. C., S. L. Emery, C. A. Spiegel, P. A. Bradford, S. Eells, A. Endimiani, R. A. Bonomo, and J. E. McGowan, Jr. 2009. Identification of plasmid-mediated AmpC β-lactamases in Escherichia coli, Klebsiella spp., and Proteus species can potentially improve reporting of cephalosporin susceptibility testing results. J. Clin. Microbiol. 47:294-299.
12. CMY-bearing plasmids among clinical Escherichia coli and Klebsiella pneumoniae isolates and emergence of cefepime-hydrolyzing CMY-19. Antimicrob. Agents Chemother. 50:534-541.
13. Walther-Rasmussen, J., and N. Hoiby. 2002. Plasmid-borne AmpC β-lactamases. Can. J. Microbiol. 48:479-493.